The study shows a cancer treatment strategy focused on the use of IGA antibodies that can target and kill tumor-promoting molecules found in cancer cells. | Health
Krebsforschung: Immuntherapie bald für die breite Masse verfügbar? heilpraxisnet.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heilpraxisnet.de Daily Mail and Mail on Sunday newspapers.
Researchers have independently validated industry-leading blood tests that can detect the DNA released by tumours.
An international team today reports the findings of an independent assessment of five commercially-available assays for tumour DNA sequencing – a fast, cheap and less invasive method to diagnose and monitor cancer.
The researchers revealed that all assays could reliably detect so-called circulating tumour DNA (ctDNA) when it made up 0.5% of the total DNA in blood, a level of sensitivity that allows detection, genetic analysis and monitoring of late-stage and metastatic tumours.
Published in the journal Nature Biotechnology, the study is a major milestone for the use of ctDNA assays as cancer diagnostics, outlining best-practice guidelines and uncovering key areas of future development.
Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist other forms of treatment..